We're Here to Help, Set Up A Free Consultation Today!
New to Fagron Sterile Services US? Interested in a new product? Let's talk.
Whether you’re looking to get up and running quickly with one of our new product offerings, or you’re interested in a Committed Supply Program, we’re ready to roll up our sleeves and help.
Fagron has been providing trusted pharmaceutical compounding services since 1990, and FSS US serves over 7,300 customers and their patients across North America.
We can talk you through some of the most common features and benefits of our sterile compounding services and share how other customers have switched to Fagron Sterile Services US without looking back. We specialize in:
|• OR Syringes||• Ophthalmics|
|• IV Admixtures||• Pain Management|
|• Urology||• Dialysis|
|• Adjunct Solutions||• Controlled Substances|
As a forward-thinking pharmaceutical supplier, Fagron has been at the forefront of shaping industry standards in sterile preparations for nearly three decades and Fagron Sterile Services US was one of the first 503Bs in the country to register with the FDA.
We are a solution you can rely on.
Why Over 7,300 Customers Trust Fagron Sterile Services US
Customer is Number 1
Our Commitment to Service Relationships is Important to Us. You can always talk directly to a member of our friendly and knowledgeable staff who will handle your requests quickly and accurately. One of our sales representatives can even travel to see you face-to-face – listen carefully to your particular needs, ask questions and then provide solutions to your sterile product needs.
A Leader in Quality Oversight. We comply with all FDA and DEA regulations, cGMP, GDP, cGLP and strive to achieve the highest quality standards within the industry — with industry-leading automation, 16 ISO 5 classified aseptic processing environments, state-of-the-art environmental monitoring and batch 100% tested for sterility, endotoxin, P.M. and potency.
Leading the Future of Compounding Through Research & Development. With over 200 pharmacists and 20 researchers working to continually develop innovative concepts and solutions to meet the growing need for ready-to-use medications, we aim to pioneer solutions to clinical challenges that change the paradigm for how therapy is delivered.